CERS · Cerus Corp
Market Cap
$521.95M
Shares
201.52M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| William M. Greenman | President and Chief Executive Officer | $3,794,657 |
| Vivek Jayaraman | Chief Operating Officer | $2,204,198 |
| Kevin Green | Chief Financial Officer | $1,750,398 |
| Chrystal Jensen | Chief Legal Officer, General Counsel and Secretary | $1,622,257 |
| Richard Benjamin | Chief Medical Officer | $1,506,553 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| William M. Greenman | President and Chief Executive Officer | $2,975,617 |
| Vivek Jayaraman | Chief Operating Officer | $1,483,868 |
| Kevin Green | Vice President, Finance and Chief Financial Officer | $1,268,994 |
| Richard Benjamin | Chief Medical Officer | $1,129,618 |
| Chrystal Jensen | Chief Legal Officer, General Counsel and Secretary | $1,104,756 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| William M. Greenman | President and Chief Executive Officer | $3,660,472 |
| Vivek Jayaraman | Chief Operating Officer | $1,790,279 |
| Kevin Green | Vice President, Finance and Chief Financial Officer | $1,461,572 |
| Richard Benjamin | Chief Medical Officer | $1,342,282 |
| Chrystal Jensen | Chief Legal Officer, General Counsel and Secretary | $1,310,087 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| William M. Greenman | President and Chief Executive Officer | $5,263,599 |
| Vivek Jayaraman | Chief Operating Officer | $2,489,302 |
| Kevin Green | Vice President, Finance and Chief Financial Officer | $2,014,428 |
| Richard Benjamin | Chief Medical Officer | $1,669,192 |
| Chrystal Jensen | Chief Legal Officer, General Counsel and Secretary | $1,641,613 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| William M. Greenman | President and Chief Executive Officer | $5,182,371 |
| Vivek Jayaraman | Chief Operating Officer | $2,378,416 |
| Kevin Green | Vice President, Finance and Chief Financial Officer | $2,026,856 |
| Richard Benjamin | Chief Medical Officer | $1,740,725 |
| Laurence Corash | Chief Scientific Officer | $1,719,854 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| William M. Greenman | President and Chief Executive Officer | $4,520,750 |
| Chief Operating | Officer | $2,114,952 |
| Vivek Jayaraman | Chief Operating Officer | $2,114,952 |
| Laurence Corash | Chief Scientific Officer | $1,412,161 |
| Richard Benjamin | Chief Medical Officer | $1,411,466 |
| Kevin Green | Vice President, Finance and Chief Financial Officer | $1,384,707 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| William M. Greenman | President and Chief Executive Officer | $3,270,179 |
| Vivek Jayaraman | — | $1,312,270 |
| Chief Operating | Officer | $1,312,270 |
| Laurence Corash | Chief Scientific Officer | $1,287,734 |
| Richard Benjamin | Chief Medical Officer | $1,261,459 |
| Kevin Green | Vice President, Finance and Chief Financial Officer | $1,249,932 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| William M. Greenman | President and Chief Executive Officer | $2,983,442 |
| Chief Operating | Officer | $1,093,862 |
| Laurence Corash | Chief Scientific Officer | $1,040,263 |
| Kevin Green | Vice President, Finance and Chief Financial Officer | $1,022,274 |
| Richard Benjamin | Chief Medical Officer | $1,013,212 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| William M. Greenman | President and Chief Executive Officer | $2,123,573 |
| Laurence Corash | Chief Scientific Officer | $871,347 |
| Richard Benjamin | Chief Medical Officer | $839,461 |
| Kevin Green | Vice President, Finance and Chief Financial Officer | $815,220 |
| Chief Operating | Officer | $670,895 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| William "Obi" Greenman | Executive Chairman of the Board | Appointed | 2026-07-10 |
| Ann Lucena | Director | Appointed | 2026-06-03 |
| William M. Greenman | Director | Appointed | 2026-06-03 |
Key facts
CIK
1020214
CUSIP
157085101
13F (30d)
149 filings
147 filers
Visit website
Investor relations